13F

Stock

Ensysce Biosciences, Inc.

ENSC · held by 17 managers

Reported value

$437.1K

Holders

17

+0 new · −0 exited

Holders’ est. mark

−$40

Price effect on 2 books still in the name

Largest holder

$137.7K

ADAGE CAPITAL PARTNERS GP, L.L.C.

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
ADAGE CAPITAL PARTNERS GP, L.L.C.149.7K$137.7KHeld
DRW Securities, LLC98.5K$90.6KHeld
PERCEPTIVE ADVISORS LLC86.7K$79.7KHeld
Vanguard36.7K$33.8KHeld
Financial Plan, Inc.24K$22.1KHeld
GEODE CAPITAL MANAGEMENT, LLC22.1K$20.3KHeld
TWO SIGMA SECURITIES, LLC21.6K$19.9KHeld
Williams & Novak, LLC17.9K$16.4KHeld
TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC12K$11KHeld
Tower Research Capital LLC (TRC)5.32K$4.89KHeld
SBI Securities Co., Ltd.421$387Held
UBS Group AG100$92Held
BANK OF AMERICA CORP /DE/72$66−$35Added$9
BlackRock, Inc.65$60Held
JONES FINANCIAL COMPANIES LLLP41$38Held
HRT FINANCIAL LP24.5K$22Held
FNY Investment Advisers, LLC3K$2−$5Cut−$5

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.